Ru Liu-Bryan results 2
· Newest (Page 1/1, per page 25)
Author: Ru Liu-Bryan ×Clear All Filters
Search Results
The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic targetNARA Subscribed
Objectives Cellular NAD + declines in inflammatory states associated with increased activity of the leukocyte-expressed NADase CD38. In this study, we tested the potential role of therapeutically targeting CD38 and NAD + in gout. Methods We studied cultured mouse wild type and CD38 knockout (KO) murine bone marrow derived macrophages (BMDMs) stimulated by monosodium urate (MSU) crystals and used the air pouch gouty inflammatio...
Previous1Next